Skip to content

Arrowhead Research ARWR Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

AbbVie logo
AbbVieABBV
$7.99B+100%
Amgen logo
AmgenAMGN
$3.96B
Johnson & Johnson logo
Johnson & JohnsonJNJ
$0-100%
Tenet Healthcare logo
Tenet HealthcareTHC
$14M+1,300%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: Arrowhead Research’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's debt issuance proceeds?
Arrowhead Research (ARWR) reported debt issuance proceeds of $3.16M in Q3 2025.
What does debt issuance proceeds mean?
Cash received from taking on new debt.
How do you interpret debt issuance proceeds?
Higher issuance increases available liquidity but also raises future interest obligations and financial leverage.
How does debt issuance proceeds compare across companies?
Biotech firms often issue debt when interest rates are favorable or when they need to extend their cash runway.